Abstract: Importantly, the high frequency of some notable mutations such as
E109A/Y,
A110S/K,
Y111D/E, and
F112L was first time reported in the entire study population.
Result: Moreover, some non-reported mutations such as
E109A/Y (43.75%),
A110S/K (37.5%),
Y111D/E (50%), and
F112L (43.75%) were also found in high frequency in
HCC and
LC (14.28%, 14.28%, 28.2% and 42.8% respectively) patients as compared to
CHB (12.8%, 15.2%, 16.8% and 16% respectively) (Figs 2 and 3).